Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside.
about
Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy.Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells.Immune Checkpoint Blockade Biology in Mouse Models of Glioblastoma.Neuroblastoma chemotherapy can be augmented by immunotargeting O-acetyl-GD2 tumor-associated ganglioside.Immunotherapies for malignant glioma.
P2860
Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside.
@en
Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside.
@nl
type
label
Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside.
@en
Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside.
@nl
prefLabel
Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside.
@en
Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside.
@nl
P2093
P2860
P356
P1433
P1476
Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside.
@en
P2093
Delphine Loussouarn
Denis Cochonneau
Fanny Geraldo
Julien Fleurence
Lisa Oliver
Mickaël Terme
Mylène Dorvillius
Sophie Fougeray
Stéphane Birklé
P2860
P304
41172-41185
P356
10.18632/ONCOTARGET.9226
P407
P577
2016-05-09T00:00:00Z